Skip to content
Governance Register

← US public companies

Spring Bank Pharmaceuticals, Inc.

SEC CIK 1566373 · SBPH · last insider filing 2023-03-09

Directors (from insider filings)

NameCapacity as filedFilings
Arkowitz David Director filed 2016 - 2023
Bermingham Nessan Director filed 2020 - 2023
Brady Todd C Director filed 2016 - 2023
Klein Pamela M. Director filed 2019 - 2023
Forster Eliot Director · President and CEO filed 2020 - 2023
Benz Edward JR Director filed 2020 - 2023
Race Geoffrey Director filed 2020 - 2023
Krol Patrick Johan Hendrik Director filed 2020 - 2021
Driscoll Martin J Director · President and CEO filed 2016 - 2020
Eichler Kurt M Director filed 2016 - 2020
Iyer Radhakrishnan P. Director · Chief Scientific Officer filed 2016 - 2020
Clackson Timothy P Director filed 2018 - 2020
Smith Scott Andrew Director filed 2018 - 2020
Freve Jonathan Director · CFO, Treasurer & Secretary filed 2016 - 2020
Bardon Christiana Director filed 2017 - 2018
Bates Jonathan Director filed 2016 - 2018

Officers (from insider filings)

NameTitle as filedFilings
Deptula-Hicks Darlene M Treasurer and CFO filed 2020 - 2023
Brewis Neil Chief Scientific Officer filed 2020 - 2023
Kayitalire Louis Chief Medical Officer filed 2020 - 2023
Winslow Garrett General Counsel and Secretary filed 2020 - 2020
Firmani Lori VP of Finance and Treasurer filed 2020 - 2020
Afdhal Nezam H. Chief Medical Officer filed 2016 - 2019

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.